Goldman goes bullish and adjusts price target

Discussion in 'Acorda Therapeutics' started by anonymous, Oct 18, 2019 at 10:57 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    The people that are unhinged are the ones the drover this company to the ground.
     

  2. anonymous

    anonymous Guest

    not true and certainly looks like a post by a disgruntled employee. give the management team a chance to prove you are incorrect and can minimize entropy and turn this around very quickly ! our shareprice is already going uptown.
     
  3. anonymous

    anonymous Guest

    Your management team had plenty of chances with a full team of employees and failed miserably... are you that dilussional that post lay-off you will perform better with less folks? Your out of runway and close to being delisted on NASDAQ.
     
  4. anonymous

    anonymous Guest

    Wall Stret loves to see fiscal discipline. The unfortunate career reassignments were necessary. Our numbers have thus improved, from cash flow, free cash, and RoI metrics and decreased entropy. Expect nice price rebound in ACO R !
     
  5. anonymous

    anonymous Guest

    FFS Habib, you hit another 52 week low yesterday. You are solidly below $2.

    Management has had over two years to get their shit together and have blown every single thing they have touched.

    Take your severance and find a new dog to pimp. This one is dead.
     
  6. anonymous

    anonymous Guest

    Your fiscal discipline, as you mentions is nothing more than a desperate window dressing for the street. Your saving with restructuring will be accretive in q1 2020 and be short lived in the absence of any material growth. This restructure is not a panacea, so you better show us what your made of. Any dip below $1.00 for a period of time will result in delisting... or the ever popular reverse split. 1:10 reverse split will annihilate your equity and dilute outstanding shares by 90%.
     
  7. anonymous

    anonymous Guest

    Our leaders have many options to rebound shareprice; yes many. Possible actions are a stock buyback at $2.00 per share, a reverse split 5 to 1 to raise shareprice to $10, or co-mingling with another pharma company to inflate shareprice by joint ownership. All approaches have pros and cons. Our inspired and genius level managers will make the best choice, if any.
     
  8. anonymous

    anonymous Guest

    "A reverse split 5 to 1 to raise shareprice to $10" ???

    WHO ARE YOU FOOLING CHAIM ???

    What a scam !!!

    If you spend 100 bucks to buy a 100 shares at a dollar.
    And now you do a 5-to-1 reverse split of the 100 shares into 20 shares.
    Yes, each one of those shares is now worth $ 5 - but the total value of your investment STILL is $ 100.

    IDIOT. Makes no difference, Habib from Pakistan or Chaim from Israel.
    Same IDIOT with a different accent and tunic.
     
  9. anonymous

    anonymous Guest

    Great incentive. Placed my order for 50,000 shares.
     
  10. anonymous

    anonymous Guest

    Sure you did Habib.

    This is dollars, not rupees and goats.

    Congrats on back to back 52 week lows. Totally ballbusting it!
     
  11. anonymous

    anonymous Guest

    you don’t have working capital for a buyback. Reverse split to $10 share will replicate the free fall of your stock your leadership created. So grab your calculator and figure how much more you will loose after a reverse split to $10 then another drop to $2. You will have a market cap value of $9m. Reverse splits scream trouble and almost never rebound unless you flush out your leadership. So stay and drink the koolaid, you must be one of those that could not get better jobs that your colleagues got when they abandoned ship. Stay where u are you .....fit well with underperformers.
     
  12. anonymous

    anonymous Guest

    A true genius leader would have avoided your current situation .